CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Oncolytics Biotech Shares Climb Ahead of Planned FDA Meeting on REO 033 Trial (ONCY)

RegulatoryREO 033Positive
AI Analysis

Summary

Oncolytics Biotech shares are rising in anticipation of a planned FDA meeting regarding their REO 033 trial. The article provides minimal details about the meeting specifics or trial outcomes.

Clinical Trial Data

Importance:5/10
Sentiment:
0.30
FDA meetingREO 033stock movementregulatory
Related Companies

Read the original article

Published by yahoo_finance on July 13, 2026 2:13 PM

Read Original